Circulating Cell-Free DNA Methylation Profiles in the Early Detection of Ovarian Cancer: A Scoping Review of the Literature
Epithelial ovarian cancer is the most lethal gynecologic malignancy and has few reliable non-invasive tests for early detection or diagnosis. Recent advances in genomic techniques have bolstered the utility of cell-free DNA (cfDNA) evaluation from peripheral blood as a viable cancer biomarker. For m...
Main Authors: | Xiaoyue M. Guo, Heather Miller, Koji Matsuo, Lynda D. Roman, Bodour Salhia |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/4/838 |
Similar Items
-
Platelet protein biomarker panel for ovarian cancer diagnosis
by: Marta Lomnytska, et al.
Published: (2018-01-01) -
A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA
by: Sofia Salta, et al.
Published: (2018-11-01) -
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
by: Xianliang Cheng, et al.
Published: (2017-11-01) -
Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum
by: Margaret L. Thomas, et al.
Published: (2018-04-01) -
Expression of the miR-200 family in tumor tissue, plasma and urine of epithelial ovarian cancer patients in comparison to benign counterparts
by: Kalle Savolainen, et al.
Published: (2020-07-01)